Health Care • Industrial Specialties
$6.64 ▲ +0.24
(+3.75%)
MKT CAP: $80.7M • VOL: 12.6K
52W L $3 52W H $9
ROARABLE / RQD
D- • 39/100
PIOTROSKI
4 / 9
NTRB // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.0M | $2.1M | $2.1M |
| YoY Revenue Growth % | -4.8% | +2.6% | — |
| Gross Profit | $566.3K | $743.3K | — |
| Gross Margin % | 27.8% | 34.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.3M | -$10.3M | -$4.9M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$8.2M | -$10.5M | -$5.5M |
| EBITDA (Normalized) | -$8.3M | -$10.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.1M | -$4.6M | -$3.5M |
| Capital Expenditures (CapEx) | $5.3K | $92.0K | — |
| Free Cash Flow (FCF) | -$5.1M | -$4.7M | -$3.5M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $4.6M | $4.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $6.7M | $6.4M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NTRB.